When.com Web Search

  1. Ads

    related to: small biotech companies to watch today in the world right now

Search results

  1. Results From The WOW.Com Content Network
  2. 3 Dirt Cheap Stocks to Buy Right Now - AOL

    www.aol.com/3-dirt-cheap-stocks-buy-113600246.html

    Prosper Junior Bakiny (CRISPR Therapeutics): Valuing relatively small biotech companies that generate little-to-no revenue is not an exact science. Even so, CRISPR Therapeutics, a gene-editing ...

  3. 3 No-Brainer Biotech Stocks to Buy With $200 Right Now - AOL

    www.aol.com/3-no-brainer-biotech-stocks...

    Image source: Getty Images. 1. Viking Therapeutics. Viking Therapeutics (NASDAQ: VKTX) is working on a candidate designed to address one of today's highest-growth areas: weight loss. The weight ...

  4. 3 No-Brainer Biotech Stocks to Buy With $200 Right Now - AOL

    www.aol.com/3-no-brainer-biotech-stocks...

    Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » 1. BioNTech. Biotech stocks usually appeal more to aggressive growth investors, while ...

  5. 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

    www.aol.com/finance/2-top-biotech-stocks-buy...

    With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...

  6. The Ultimate Biotech Stock to Buy With $50 Right Now - AOL

    www.aol.com/ultimate-biotech-stock-buy-50...

    Case in point: Bluebird Bio is a biotech company with three approved gene-editing treatments, but its stock continues to perform terribly. Revenue isn't coming fast enough for investors to change ...

  7. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.